EBMcalc G.I. vs AGA MASH App

EBMcalc G.I. EBMcalc is the most popular and comprehensive Medical Calculator system on the web. It has been highly acclaimed, reviewed and tested over the last 25 years. EBMcalc users should not make any medical decisions based on app content without seeking their doctor's advice. EBMcalc G.I. encompasses numerous medical equations, clinical criteria sets, decision tree tools and dose/unit converters used every day by Gastroenterology specialists. With the growing emphasis on Evidence-Based Medicine, there has never been a greater need for a system such as EBMcalc. Equations included: Ascites Albumin Gradient Fractional Excretion of Amylase (Amylase to creatinine clearance ratio) Hepatitis C Fibrosis Prediction Score MELD Score for End-Stage Liver Disease (NOT appropriate for patients under the age of 12) (SI units) MELD Score for End-Stage Liver Disease (NOT appropriate for patients under the age of 12) MELDNa Score for End-Stage Liver Disease (NOT appropriate for patients under the age of 12) (SI units) MELDNa Score for End-Stage Liver Disease (NOT appropriate for patients under the age of 12) Mortality risk in post-operative patients with cirrhosis (SI units) Mortality risk in post-operative patients with cirrhosis PELD Score for End-Stage Liver Disease (patients less than 12 years old) Stool Osmolal Gap TIPS Risk predictor / Survival predictor (Transjugular Intrahepatic Portosystemic Shunt) Clinical Criteria Sets included: Acetaminophen (Paracetamol) Toxicity Assessment Alcoholic Liver Disease Combined Index (Clinical and Laboratory -- CCLI) Criteria for One Year Mortality Prognosis Alcoholic Liver Disease: Criteria for One Year Mortality Prognosis Autoimmune Hepatitis Diagnostic Criteria Bedside index of severity in acute pancreatitis (BISAP) score Blatchford Score for Gastrointestinal Bleeding Bowel Obstruction Diagnosis: Utility of X-ray Child Pugh Classification for Severity of Liver Disease (SI units) Child Pugh Classification for Severity of Liver Disease Cirrhosis Probability in Hepatitis C (6 models) Crohn's disease activity index (CDAI) Esophageal Varices: Prediction from Platelet Count to Spleen Diameter Ratio Glasgow alcoholic hepatitis score Harvey-Bradshaw index of Crohn's disease activity Hepatitis C Cirrhosis Probability Hepatitis Discriminant Function for Corticosteroid Therapy in Alcoholic Hepatitis Irritable Bowel Syndrome Diagnostic Criteria (Manning Criteria) Lower GI Bleeding and Risk of Severe Bleeding Mayo Score for Assessing Ulcerative Colitis Activity Nonbiliary Cirrhosis Prognostic Criteria for One Year Survival Omeprazole Therapeutic Gain (over placebo) in Dyspepsia Omeprazole Therapeutic Index in Dyspepsia Pancreatitis Prognosis Criteria When Disease Due To Gallstones Pancreatitis Prognosis Criteria Rockall Score for Upper Gastrointestinal Bleeding Decision Trees included: Barrett Esophagus Progression Risk TreeCalc Hepatitis C Outcome TreeCalc NASH Fibrosis Risk (Nonalcoholic Steatohepatitis) TreeCalc Unit and Dose Converters include: Area Unit Conversions Basic Unit Conversions Comprehensive Unit Conversions Corticosteroid Medication Dosing Conversions (glucocorticoid effect) Corticosteroid Medication Dosing Conversions (mineralocorticoid effect) Density Unit Conversions Energy Unit Conversions Fentanyl Patch Initial Dosing Estimate Based on Prior Narcotic Dosing Flow Unit Conversions Force Unit Conversions Length Unit Conversions Opioid Medication Dose Conversions Oxygen Delivery Units Conversions Power Unit Conversions Pressure Unit Conversions SI Unit Conversions (multiple) Speed Unit Conversions Standard Drink Equivalents Temperature Unit Conversions Textile Type Unit Conversions Thyroid Medication Dosing Conversions Time Unit Conversions Volume Unit Conversions Weight Unit Conversions To practice, teach and learn medicine based on solid, literature based evidence, EBMcalc provides easy to use, interactive tools for your Evidence-Based Medicine.

American Gastroenterological Association’s MASH Clinical Care Pathway app is for use in any setting where health care professionals care for patients with MASH / MASLD, including primary care, endocrine, obesity medicine and gastroenterology practices. Developed with support by independent medical education grants from Intercept Pharmaceuticals, Inc., Pfizer Inc., Allergan, and Genfit. For more information visit gastro.org.